The intravenous infusion of high doses of histamine (400 fig base/min) produced only small increases in weight (=+30 g) and lymph total protein concentration (+0.9 g/100 ml) in canine forelimbs perfused at constant inflow. The weight gain was associated with profound decreases in aortic pressure (112 to 30 mm Hg) and in forelimb perfusion pressure (105 to 75 mm Hg) and marked increases in forelimb skin small-vein pressure (from 12 to 25 mm Hg). After treatment with phentolamine, the intravenous infusion of these doses of histamine under the same conditions produced marked decreases in forelimb perfusion pressure (120 to 60 mm Hg) and failed to increase forelimb skin small-vein pressure, yet still produced only minimal increases in weight (+12 g) and lymph total protein concentration (+0.8 g/100 ml). Following treatment with both phentolamine and propranolol, the intravenous infusion of histamine caused very marked increases in forelimb weight (=+75 g) and lymph total protein concentration (+2.9 g/100 ml). These marked increases in forelimb weight and lymph formation were associated with profound decreases in perfusion pressure (112 to 60 mm Hg) but no change in skin small-vein pressure relative to control. These same increases in weight and lymph total protein concentration were observed after treatment with propranolol alone. Thus, treatment with propranolol markedly increased net fluid filtration and protein efflux during intravenous infusions of massive doses of histamine, indicating that this edemogenic agent causes an endogenous release of catecholamines which tend to antagonize the direct actions of histamine on the microvascular membrane via stimulation of ^-adrenergic receptors.
LOCAL intra-arterial infusions of histamine into canine forelimbs promotes marked protein efflux and edema formation, owing to an increase in microvascular permeability to plasma proteins (Grega et al., 1972a; Haddy et al., 1972 Haddy et al., , 1976 . This increased protein efflux is reflected by marked increases in lymph flow rate and lymph total protein concentration, the latter approaching the total protein concentration of plasma with higher doses of histamine.
In contrast to local intra-arterial infusions of histamine, systemic infusions, either intravenously or into the left ventricular chamber, in doses calculated to equal or exceed those which produce massive protein efflux and edema formation during local intra-arterial infusions, fail to promote forelimb edema formation (Daugherty et al., 1968; Grega et al., 1972b; Marciniak et al, 1977) . In fact, a dose-dependent forelimb extravascular fluid reabsorption occurs during prolonged intravenous infusions of histamine. Lymph total protein concentra-tion was increased only minimally during the intravenous infusion of histamine compared to the large increase in lymph protein concentration produced by local intra-arterial infusions of histamine (Marciniak et al., 1977) . This small increase in lymph total protein concentration can be explained, in part, by extravascular fluid reabsorption which slightly concentrates interstitial fluid protein.
This route-dependent differential action of histamine on fluid filtration has long been noted (Daugherty et al., 1968; Grega et al., 1972b) but has generated little interest with regard to its mechanism. Recent studies from this laboratory (Marciniak et al., 1977) have demonstrated that the routedependent effect on fluid filtration is not largely attributable to the degradation of histamine in the pulmonary vascular bed nor to decreases in blood flow and microvascular pressure. We found that in forelimbs perfused at constant inflow the intravenous infusion of high doses of histamine still produced minimal increases in protein efflux and edema formation relative to that produced by local intra-arterial infusions despite greatly increasing microvascular pressure.
It also has been demonstrated that local intraarterial infusions of catecholamines with histamine or bradykinin into the canine forelimb antagonizes (Svensjo et al., 1979; Maciejko et al., 1978; Marci-niak et al., 1978) the direct actions of histamine and bradykinin on the microvascular membrane and by stimulation of /?-adrenergic receptors largely prevents the increase in protein efflux and edema formation caused by these agents. This antagonism of histamine and bradykinin protein efflux is completely independent of changes in blood flow, microvascular pressure, and perfused surface area Marciniak et al., 1978; Rippe and Grega, 1978) . Instead, it reflects a direct action of the catecholamine on the microvascular membrane which counteracts that produced by histamine and bradykinin. It has been shown by intravital microscopy using fluorescent macromolecular tracers that histamine and bradykinin (Haddy et al., 1976; Svensjo et al., 1977 Svensjo et al., , 1979 ) create a marked increase in the number of large venular gaps owing to endothelial cell separation in the small venules through which macromolecules rapidly leak into the interstitium. Moreover, this histamine-induced venular gap formation is greatly reduced by catecholamines (Svensjo et al., 1977 (Svensjo et al., , 1979 , and this antagonism can be prevented by treatment with propranolol. Because histamine elicits a direct release of adrenal catecholamines and, on systemic administration, causes an indirect sympathoadrenal discharge subsequent to severe hypotension, it has been suggested (Marciniak et al, 1977 Maciejko et al., 1978) that an endogenous release of catecholamines may account, in part, for this routedependent differential action of histamine on protein efflux and fluid filtration. This suggestion is supported further by data demonstrating that local intra-arterial infusions of histamine in doses that produce massive protein efflux and edema formation exert minimal effects on protein efflux if infused into forelimbs perfused at constant inflow with autologous blood from animals subjected to prior systemic hypotension produced by either hemorrhage or intravenous infusions of large doses of acetylcholine or histamine itself (Marciniak et al, 1977; Maciejko et al., 1978) . In contrast, histamine infused intra-arterially into forelimbs perfused at constant inflow still markedly increases protein efflux in animals subjected to local forelimb hypotension (Grega et al., 1972a) . In this study, we compared the effects of intravenous infusions of histamine alone on protein efflux and edema formation and also in the presence of adrenergic receptor blockade with propranolol and/or phentolamine.
Methods
Mongrel dogs of either sex weighing 12-27 kg were anesthetized with pentobarbital sodium (30-35 mg/kg, iv) and ventilated with room air by use of a Harvard respiratory pump. Small incisions were made over the brachial artery, cephalic vein (above the elbow), and second superficial dorsal metacarpal vein (paw) in the right forelimb. A side branch of the brachial artery, a lymph vessel, and the vein were isolated. After heparin had been administered intravenously (350 jti/kg), these vessels were cannulated in an upstream direction with polyethylene tubing for drug administration, lymph collection, and pressure measurement, respectively. The lymph vessels in the area of the cephalic vein above the elbow drain forelimb skin and paw (Haddy et al., 1972) . Two or three lymph vessels usually were tied centrally, and one of them was cannulated distally with a 10-cm length of PE-10 tubing which had been beveled at the cannulating end. A sigmamotor pump was used to maintain constant blood inflow through the brachial artery throughout the experiment. Initially, flow was set at a rate that produced a perfusion pressure similar to aortic pressure.
Lymph was collected in 0.5-ml graduated cylinders constructed from plastic pipettes.. The drugs were infused into the brachial artery with a Harvard infusion pump. The skin small-vein pressure and aortic pressure (via a femoral artery) were measured with low-volume displacement Statham pressure transducers. Blood was collected periodically from the brachial artery for plasma protein and hematocrit determinations. Lymph collections were for 10-minute periods, and pressures were measured at the end of each 10-minute period. Total protein concentration in lymph and plasma was measured by the spectrophotometric (Beckman DB spectrophotometer) method of Waddell (1956) .
Histamine (200 or 400 fig base/min) was infused intravenously for 60 minutes after a 30-minute control period. Some dogs were treated with propranolol and/or phentolamine prior to initiating and during the intravenous infusion of histamine. Phentolamine (200 jug base/min) was infused intra-arterially during the control and histamine infusion periods, whereas propranolol was given intravenously (2 mg/kg) 20 minutes prior to initiating the histamine infusion and intra-arterially (200 /xg/min) during the control and histamine infusion periods. The intravenous histamine infusion was started 20 minutes after initiating treatment with the adrenergic-blocking agents. Control responses to all vasoactive agents (phentolamine, propranolol, phentolamine plus propranolol) used also were studied systematically. Histamine (16 /xg base/min) also was infused intra-arterially for 60 minutes into forelimbs perfused at constant inflow. In other dogs, this same dose of histamine was infused intra-arterially after treatment with phentolamine and/or propranolol. The weight of the experimental forelimb was compared to that of the contralateral forelimb on cessation of the infusions. Unless otherwise specified, six dogs were employed in each group studied. The forelimbs were isolated at the elbow removing all soft tissue and sectioning the bone precisely at the elbow. Therefore, each dog served as its own control.
Data are reported as mean ± SE. The weight difference between the experimental and contralateral forelimbs was statistically compared employing VOL. 47, No. 4, OCTOBER 1980 Student's f-test. The other data were statistically analyzed by analysis of variance (randomized complete block design). The means were compared by the least significant difference test. A summary table of all data (Table 5) is presented in which data are analyzed statistically and comparisons made among groups.
Results

Intravenous Infusions of Histamine Forelimb Weight: Control Animals and Histamine (400 fig base/min)
In twelve control animals, the mean weights of the experimental and contralateral forelimbs were not significantly different after the 60-minute saline infusion period, 2 ± 3 g. After cessation of the 60minute infusion of histamine alone or histamine following treatment with phentolamine, the mean weight of the experimental limb exceeded the weight of the contralateral forelimb by 31 ± 6 and 12 ± 5 g, respectively. The mean weight of the experimental limb exceeded the mean weight of the contralateral limb by 76 ± 11 and 58 ± 9 g after cessation of the histamine-phentolamine-propran-olol and histamine-propranolol infusions, respectively.
Lymph Flow and Protein Concentration at Constant Inflow
Histamine (200 ng base/min) ( Table 1) . The intravenous infusion of histamine for 60 minutes produced large decreases in aortic pressure and, in forelimbs perfused at constant inflow, only transient decreases in perfusion pressure and no change in skin small-vein pressure. Lymph flow rate and lymph total protein concentrations were not increased significantly. No visible evidence of edema formation was present.
Following treatment with phentolamine, the intravenous infusion of histamine produced large decreases in aortic pressure and, in the forelimb, large decreases in perfusion pressure but no change in skin small-vein pressure. The increase in lymph flow rate was at maximum values statistically significant, whereas the small increase in lymph total protein concentration was not statistically significant. Visible evidence of edema formation was not present. After treatment with both phentolamine and propranolol, histamine produced large decreases in aortic pressure and, in the forelimb, produced large decreases in perfusion pressure but no change in skin small-vein pressure. Lymph flow and lymph total protein concentration both were increased markedly. The forelimb was firm to the touch and visibly swollen after 30 minutes, providing evidence of edema formation.
Histamine (400 ng base/min) ( Table 2 ). The infusion of histamine produced marked decreases in aortic pressure and, in the forelimb, small decreases in perfusion pressure, marked increases in skin small-vein pressure, large increases in lymph flow rate, but only small increases in lymph protein concentration.
Following treatment with phentolamine, histamine produced profound decreases in aortic pressure and, in the forelimb, produced marked decreases in perfusion pressure but no change in skin small-vein pressure. Lymph flow rate still was increased substantially, yet the increase in lymph total protein concentration was small.
After treatment with both phentolamine and propranolol, histamine again produced profound decreases in aortic pressure and, in the forelimb, marked decreases in perfusion pressure yet no change in skin small-vein pressure. However, lymph flow and lymph total protein concentration were increased markedly.
Following treatment with propranolol alone, the intravenous infusion of histamine produced a transient decrease in perfusion pressure and a sustained increase in skin small-vein pressure. Perfusion pressure then increased to near control levels by the end of the infusion period. Lymph total protein concentration was increased markedly, whereas the increase in lymph flow rate was considerably less than that produced following treatment with both phentolamine and propranolol. Skin small-vein pressure (mm Hg) 10 ± 1 10 ± 1 10 ± 1 10 ± 1 10 ± 1 9 ± 1 9 + 1 9 ± 1 9 ± 1 9 ± 1 11 ± 1 11 ± 1 11 ± 1 11 ± 1 11 ± 1
Lymph flow rate (ml/10 min) 0.01 ± 0 0.01 ± 0 0.01 ± 0 0.01 ± 0 0.01 ± 0 0.02 + 0 0.02 + 0 0.02 ± 0 0.02 ± 0 0.02 ± 0 0.02 ± 0 0.02 ± 0 0.02 ± 0 0.02 ± 0 0.02 ± 0
Lymph total protein concentration (g/100 ml) Phentolamine 2.5 ± 0.3 2.5 ± 0.3 2.5 ± 0.3 2.5 ± 0.3 2.3 ± 0.3 Phentolamine and propranolol 2.0 + 0.2 2.0 + 0.2 2.0 ± 0.2 2.0 + 0.2 2.0 ± 0.2 Propranolol 1.9 ± 0.2 1.9 ± 0.3 1.9 ± 0.2 1.9 ± 0.2 1.9 ± 0.2 Phentolamine, 200 ^g/min, ia from 0 to 60 minutes; propranolol, 2 mg/kg, iv at 0 minutes, 200 /ig/min, ia from 0 to 60 minutes.
* P < 0.05; f P < 0.01; P values compare each group to its own control at zero time; n = 6 for each group.
Control Animals and Local Intra-arterial Infusions of Histamine (Tables 3 and 4)
Lymph total protein concentration failed to change during the 60-minute local intra-arterial infusion of phentolamine, propranolol, or propranolol plus phentolamine. Histamine (16 jug base/min) caused a large increase in lymph total protein concentration. Following treatment with either phentolamine, propranolol, or phentolamine plus propranolol, the infusion of histamine still produced increases in lymph flow and lymph total protein concentration similar to those produced by the infusion of histamine alone.
The mean weights of the experimental and contralateral forelimbs were not significantly different after cessation of the 60-minute infusion except in those animals receiving histamine. Histamine infused intra-arterially for 60 minutes alone or following treatment with the various combinations of adrenergic-blocking agents produced similar marked increases in weight in the experimental limb relative to that of the contralateral control limb.
Sixty minutes following the cessation of the propranolol, phentolamine plus propranolol, or phentolamine infusions, the mean differences in weight between the experimental and the contralateral forelimbs were -2 ± 4, 0 ± 6, and 3 ± 4 g, respectively. Sixty minutes following the cessation of the local intra-arterial histamine infusion in the presence of adrenergic receptor blockade, the mean differences in weight between the experimental and contralateral forelimbs were 63 ± 9, 77 ± 11 and 74 ± 8 g in animals treated with phentolamine, propranolol, or phentolamine plus propranolol, respectively. Following the cessation of the histamine infusion alone, the weight of the experimental forelimb exceeded that of the contralateral forelimb by 73 ± 9 g. (Table 5) Table 5 is a summary comparing the effects of intravenous infusions of histamine to those during adrenergic blockade in the control period and 60 minutes after the start of the drug infusions. There were no significant differences among the various groups during the control period. However, 60 minutes after the start of the infusion, perfusion pressure and skin small-vein pressure were significantly lower during the histamine infusion with phentolamine or propranolol plus phentolamine than during the infusion of histamine alone. Lymph flow was significantly greater during the histamine infusions with phentolamine or propranolol plus phentolamine than during the infusion of histamine alone and significantly less during the infusion of histamine and propranolol than during the infusion Phentolamine, 200 jig/min, ia from -10 to 60 min; propranolol, 2 jig/kg, iv at -20 minutes, 200 /ig/min, ia from -20 to 60 minutes. * P < 0.05; f P < 0.01; P values compare each group to its own control at zero time; n = 6 for each group.
Comparison of Responses among Groups
of histamine alone. Lymph total protein concentration was significantly greater during the histamine infusion with propranolol or phentolamine plus propranolol than during the infusion with histamine alone or histamine plus phentolamine. The increase in forelimb weight was significantly greater during the histamine infusion with propranolol or phentolamine plus propranolol than during the infusion of histamine alone. The increase in forelimb weight was significantly less during the infusion of histamine with phentolamine than during the infusion of histamine alone. (400 fig base/min) for prolonged periods of time produced minimal increases in limb weight, lymph flow, and lymph protein concentration in forelimbs perfused at constant inflow relative to that produced by local intra-arterial infusions of this agent as previously reported (Haddy et al., 1976; Kline et al., 1973; Grega et al., 1972a) . The increase in weight was small ( s 30 g) and is largely attributable to edema formation as weight does not decrease on cessation of the infusion, at which time vascular resistance and, inferentially, intravascular volume return to control levels. The edema was associated with marked increases in small-vein pressure and, inferentially, microvascular pressure and with small increases in lymph protein concentration, evidence of a small increase in microvascular permeability to plasma proteins. Mechanically increasing venous pressure to similar levels in forelimbs perfused at constant inflow produces similar increases in weight (Kline et al., 1975) , suggesting that the rise in microvascular pressure is important in the genesis of the histamine edema formation under these conditions. This also is supported by the observation that pretreatment with phentolamine, which prevents the marked increase in skin small-vein pressure, resulted in substantially smaller increases in forelimb weight during the intravenous infusion of histamine. Although phentolamine abolished the increase in skin small-vein pressure produced by the intravenous infusion of histamine, lymph flow was increased to levels seen during the infusion of this dose of histamine alone. This may possibly be explained, in part, by increased fluid filtration resulting from a small increase in protein efflux and relaxation of prenodal lymphatic vessels by phentolamine facilitating drainage of the interstitium. We believe that phentolamine facilitates lymphatic VOL. 47, No. 4, OCTOBER 1980 All data during the combination infusions are compared to that produced by the infusion of histamine alone both during the control period and 60 minutes after the start of the infusion period. H = histamine, 400 jig base/min, iv; a = phentolamine, 200 jig/min, ia; /? = propranolol, 2 mg/kg, iv, and 200 jig/min, ia.
Discussion
Intravenous infusions of high doses of histamine
' P < 0.05; \P < 0.01; the comparison among groups is made at selected time intervals; n = 6 for each group.
drainage because in other studies it has been observed that infusions of histamine produce greater increases in lymph flow rate in the presence of phentolamine (Grega et al., 1980) . Although phentolamine fails to enhance histamine-induced protein efflux as judged by the increases in lymph total protein concentration in the presence or absence of phentolamine, lymph flow rates are enhanced.
Our control studies demonstrate that neither phentolamine nor propranolol, alone or in combination, produced measurable changes in lymph total protein concentration. Moreover, treatment with these agents did not alter measurably the marked increase in forelimb weight or lymph total protein concentration produced by a 60-minute local intra-arterial infusion of histamine.
Treatment with the alpha adrenergic receptorblocking agent phentolamine exerted no measurable effect on the increase in lymph total protein concentration during the intravenous infusion of the high doses of histamine relative to that produced by histamine alone. However, following treatment with both propranolol and phentolamine, prolonged intravenous infusions of high doses of histamine (400 jug base/min) elicited marked increases in weight, lymph flow, and lymph total protein concentration in forelimbs perfused at constant in-flow. The increase in weight is attributable largely to edema formation as perfusion pressure and, inferentially, intravascular volume were constant throughout the infusion period, and the limbs were visibly edematous. Perfusion pressure was decreased markedly, and skin small-vein pressure failed to increase under these conditions. This contrasts with the marked increase in small-vein pressure and the small fall in perfusion pressure during the intravenous infusion of histamine alone and suggests that the increase in small-vein pressure and the higher perfusion pressure in the latter is due to a catecholamine-induced constriction which is eliminated by the phentolamine treatment. The edema formation, therefore, is attributable to a marked decrease in the transmural colloid osmotic pressure gradient subsequent to an increase in microvascular permeability to plasma proteins, evidenced by the large increase in lymph total protein concentration and lymph flow rate. The maximum increase in lymph total protein concentration averaged 0.9 g/100 ml during the intravenous infusion of histamine alone or histamine plus phentolamine but averaged 2.9 g/100 ml during the intravenous histamine-phentolamine-propranolol infusion. Treatment with propranolol alone resulted in large increases in forelimb weight and lymph total protein concentration during the intravenous infusion of high doses of histamine despite the fact that the changes in perfusion pressure and skin smallvein pressure were similar to those produced during the intravenous infusion of this dose of histamine alone. Moreover, the increase in weight under these conditions was similar to that produced by local intra-arterial infusions (Grega et al., 1972a) of histamine (64 jug base/min). Decreasing the intravenous histamine infusion rate to 200 fig base/min failed to produce statistically significant increases in forelimb lymph total protein concentration in animals treated with phentolamine. Infusing this same dose of histamine after treatment with both propranolol and phentolamine elicited marked increases in lymph total protein concentration.
These data suggest that endogenously liberated catecholamines contribute significantly to the route-dependent differential action of histamine on the microvascular membrane and that the antagonism of histamine-induced protein efflux by catecholamines is due entirely to stimulation of ^-adrenergic receptors. Moreover, this antagonistic action of catecholamines is attributable to a direct action on the microvascular membrane which counteracts that of histamine and, under the conditions of these experiments, cannot be explained by changes in blood flow, microvascular pressure, or perfused surface area, as total blood flow was held constant with a pump.
It has long been known that sustained intravenous infusions of vasodilators produce initial vasodilation followed by vasoconstriction subsequent to hypotension-induced and possibly directly in-creased sympathoadrenal activity (Daugherty et al., 1968) . These data demonstrate that, as with changes in vascular resistances, the direct action of edema-producing agents on the microvascular membrane also may differ as a function of the route of administration owing to a possible interaction with other regulatory systems and point out possible serious errors in extrapolating data from isolated organ studies to those in the whole animal.
These data may have relevance to various shock states in which massive quantities of histamine and/or bradykinin are liberated. For example, there is surprisingly little evidence for substantial increases in microvascular permeability to plasma proteins in many anaphylactic, endotoxic, and hemorrhagic shock states despite a massive liberation of edema-producing substances (Grega et al., 1972b; Haddy et al., 1976; Maciejko et al., 1978; Marciniak et al., 1978) . The present findings suggest that the liberation of endogenous catecholamines (and possibly other substances) subsequent to hypotension and a direct action of these substances on the adrenal medulla may account, in part, for these observations. The sympathoadrenal system may function as a negative feedback system, limiting increases in permeability in various pathophysiological states associated with massive histamine release, while permitting local inflammatory responses. Thus, in contrast to the small-pore system in the capillaries, the venular large-pore system is subject to physiological and pharamcological control. Venular macromolecular permeability either may be increased markedly, maintained at control levels, or varied between these two extremes, depending on existing physiological conditions. These data do not provide evidence for a role of histamine or catecholamines in the normal regulation of microvascular permeability to macromolecules. Hence, these data are consistent with the theory of a small but fixed number of large pores, which permit a slow, steady passage of macromolecules from the blood to the interstitium. However, these data do suggest that, in conditions in which there is an endogenous release of edema-producing substances, which possess the unique ability to increase microvascular permeability to macromolecules by increasing the number of large pores, the liberation of other endogenous substances may ex-ert profound effects on microvascular permeability to macromolecules, even counteracting the direct effects of the edema-producing agents if sufficient concentrations of antagonistic endogenous substances are released.
